These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 14513684

  • 1. Dendritic cell-based cancer therapy.
    Conrad C, Nestle FO.
    Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
    [Abstract] [Full Text] [Related]

  • 2. Current issues in dendritic cell cancer immunotherapy.
    López JA, Hart DN.
    Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
    [Abstract] [Full Text] [Related]

  • 3. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 4. Dendritic cells in cancer immunotherapy.
    Gunzer M, Grabbe S.
    Crit Rev Immunol; 2001 Jun; 21(1-3):133-45. PubMed ID: 11642600
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cell vaccination for cancer therapy.
    Nestle FO.
    Oncogene; 2000 Dec 27; 19(56):6673-9. PubMed ID: 11426654
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cell-based immunotherapy.
    Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK.
    Int Rev Immunol; 2006 Dec 27; 25(5-6):377-413. PubMed ID: 17169781
    [Abstract] [Full Text] [Related]

  • 7. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D, Moyana T, Xiang J.
    Cell Res; 2006 Mar 27; 16(3):241-59. PubMed ID: 16541123
    [Abstract] [Full Text] [Related]

  • 8. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.
    Sbiera S, Wortmann S, Fassnacht M.
    Horm Metab Res; 2008 Feb 27; 40(2):89-98. PubMed ID: 18283626
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cell immunotherapy: mapping the way.
    Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ.
    Nat Med; 2004 May 27; 10(5):475-80. PubMed ID: 15122249
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.
    Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ.
    Crit Rev Oncog; 2000 May 27; 11(1):1-17. PubMed ID: 10795625
    [Abstract] [Full Text] [Related]

  • 11. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
    Rossowska J, Pajtasz-Piasecka E.
    Postepy Hig Med Dosw; 2003 May 27; 57(5):501-18. PubMed ID: 14737967
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S, Ueno H, Fay J, Banchereau J, Palucka AK.
    Semin Cancer Biol; 2003 Dec 27; 13(6):439-47. PubMed ID: 15001163
    [Abstract] [Full Text] [Related]

  • 13. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ, de Vries IJ, Torensma R, Figdor CG.
    Nat Rev Immunol; 2007 Oct 27; 7(10):790-802. PubMed ID: 17853902
    [Abstract] [Full Text] [Related]

  • 14. Advances in specific immunotherapy for prostate cancer.
    Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.
    Eur Urol; 2008 Apr 27; 53(4):694-708. PubMed ID: 18061335
    [Abstract] [Full Text] [Related]

  • 15. Current issues in delivering DCs for immunotherapy.
    Barratt-Boyes SM, Figdor CG.
    Cytotherapy; 2004 Apr 27; 6(2):105-10. PubMed ID: 15203986
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 27; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 17. Cellular immunotherapy with dendritic cells in cancer: current status.
    Nencioni A, Brossart P.
    Stem Cells; 2004 Dec 27; 22(4):501-13. PubMed ID: 15277696
    [Abstract] [Full Text] [Related]

  • 18. The use of dendritic cells in cancer immunotherapy.
    Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P.
    Crit Rev Oncol Hematol; 2008 Mar 27; 65(3):191-9. PubMed ID: 18055210
    [Abstract] [Full Text] [Related]

  • 19. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C, Taieb J, Terme M, Maruyama K, Flament C, Angevin E, Zitvogel L.
    Bull Cancer; 2003 Mar 27; 90(8-9):699-705. PubMed ID: 14609759
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells in cancer immunotherapy.
    Vulink A, Radford KJ, Melief C, Hart DN.
    Adv Cancer Res; 2008 Mar 27; 99():363-407. PubMed ID: 18037410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.